Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233701 · ClinicalTrials.gov registry record
Normal Pressure Hydrocephalus (NPH) Registry
A clinical trial, sponsored by Codman & Shurtleff.
- Completed
- Registry status
- 343
- Enrollment target
NCT00233701: Completed study, sponsored by Codman & Shurtleff.
NCT00233701 is a clinical trial that has completed, run by Codman & Shurtleff. The registered enrollment target is 343 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00233701 has completed, sponsored by Codman & Shurtleff.
- COMPLETED
- Registry status
- 343 participants
- Enrollment target
Study Summary
The overall aim of the registry is to develop a longitudinal, observational database that is focused on adult patients with Normal Pressure Hydrocephalus (NPH) that can be used as a source of clinical information for individual surgeons, as well as a national data repository for scientific inquiry and publications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-09 |
What the finished NCT00233701 record still lists
NCT00233701 is an observational study that tracks outcomes without assigning an intervention. The registered 343 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00233701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00233701 about?
NCT00233701 is a clinical study titled "Normal Pressure Hydrocephalus (NPH) Registry". The overall aim of the registry is to develop a longitudinal, observational database that is focused on adult patients with Normal Pressure Hydrocephalus (NPH) that can be used as a source of clinical information for individual surgeons, as well as a national data repository for scientific inquiry a...
What is the current status of trial NCT00233701?
This trial is currently completed. The enrollment target is 343 participants. The study started on 2004-10. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00233701?
This trial is sponsored by Codman & Shurtleff, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia